HEC121120

· Sunshine Lake Pharma Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HEC121120, covering 2024-06-24 to 2024-06-24. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study [Phase 1, Phase 2]

See pricing